ES2640532T3 - Métodos para la detección de papilomavirus humano y proporcionar un pronóstico para el carcinoma de células escamosas de cabeza y cuello - Google Patents

Métodos para la detección de papilomavirus humano y proporcionar un pronóstico para el carcinoma de células escamosas de cabeza y cuello Download PDF

Info

Publication number
ES2640532T3
ES2640532T3 ES12850526.0T ES12850526T ES2640532T3 ES 2640532 T3 ES2640532 T3 ES 2640532T3 ES 12850526 T ES12850526 T ES 12850526T ES 2640532 T3 ES2640532 T3 ES 2640532T3
Authority
ES
Spain
Prior art keywords
sample
hpv
risk
antibody
solcd44
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12850526.0T
Other languages
English (en)
Spanish (es)
Inventor
Elizabeth Franzmann
Lutecia PEREIRA
Isildinha M. REIS
Robert C. Duncan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Miami
Original Assignee
University of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Miami filed Critical University of Miami
Application granted granted Critical
Publication of ES2640532T3 publication Critical patent/ES2640532T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70585—CD44
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
ES12850526.0T 2011-11-15 2012-11-15 Métodos para la detección de papilomavirus humano y proporcionar un pronóstico para el carcinoma de células escamosas de cabeza y cuello Active ES2640532T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161559974P 2011-11-15 2011-11-15
US201161559974P 2011-11-15
US201261654595P 2012-06-01 2012-06-01
US201261654595P 2012-06-01
PCT/US2012/065282 WO2013074793A1 (en) 2011-11-15 2012-11-15 Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

Publications (1)

Publication Number Publication Date
ES2640532T3 true ES2640532T3 (es) 2017-11-03

Family

ID=48430146

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12850526.0T Active ES2640532T3 (es) 2011-11-15 2012-11-15 Métodos para la detección de papilomavirus humano y proporcionar un pronóstico para el carcinoma de células escamosas de cabeza y cuello

Country Status (13)

Country Link
US (3) US20140329230A1 (https=)
EP (1) EP2780714B1 (https=)
JP (1) JP6174035B2 (https=)
CN (1) CN104067126B (https=)
AU (3) AU2012340441A1 (https=)
BR (1) BR112014011563B1 (https=)
CA (1) CA2855971C (https=)
CO (1) CO6980621A2 (https=)
ES (1) ES2640532T3 (https=)
IL (1) IL232556A (https=)
MX (1) MX352642B (https=)
PE (1) PE20141565A1 (https=)
WO (1) WO2013074793A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012340441A1 (en) 2011-11-15 2014-05-29 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
WO2015017692A1 (en) * 2013-07-31 2015-02-05 University Of Miami Compositions and methods for identifying a risk of cancer in a subject
WO2015026827A2 (en) * 2013-08-19 2015-02-26 University Of Notre Dame Method and composition for detection of oncogenic hpv
WO2015179712A1 (en) 2014-05-22 2015-11-26 University Of Notre Dame Du Lac Integrated membrane sensor for rapid molecular detection
WO2016209703A1 (en) * 2015-06-22 2016-12-29 The Johns Hopkins University Head and neck squamous cell carcinoma assays
JP6655243B2 (ja) * 2015-09-01 2020-02-26 国立大学法人 鹿児島大学 口腔前癌病変の検出方法
CN107092854B (zh) * 2016-02-18 2020-05-22 财团法人金属工业研究发展中心 检测细胞受人类乳头瘤病毒(hpv)感染的装置及其检测方法
GB201808839D0 (en) 2018-05-30 2018-07-11 Cancer Research Tech Ltd Method of predicting survival rates for cancer patients
WO2020018954A1 (en) * 2018-07-20 2020-01-23 Predentome, Inc. Methods and systems for oral microbiome analysis
US20220137041A1 (en) * 2019-02-26 2022-05-05 University Of Miami Device for methods of detecting cancer
US20240188897A1 (en) * 2021-04-23 2024-06-13 The University Of Chicago Machine learning based histopathological recurrence prediction models for hpv+ head / neck squamous cell carcinoma
CN120359416A (zh) * 2022-10-17 2025-07-22 伟吉朗特生物科学公司 用于口腔癌风险的方法和组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403551A (en) 1993-09-16 1995-04-04 Roche Diagnostic Systems, Inc. Assaying device and container for in field analysis of a specimen and later shipment of the unadulterated specimen
US6235470B1 (en) 1993-11-12 2001-05-22 The Johns Hopkins University School Of Medicine Detection of neoplasia by analysis of saliva
US5990299A (en) * 1995-08-14 1999-11-23 Icn Pharmaceuticals, Inc. Control of CD44 gene expression for therapeutic use
US5976895A (en) 1996-03-11 1999-11-02 American Biomedica Corporation Device for the collection, testing and shipment of body fluid samples
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US6379620B1 (en) 1998-11-16 2002-04-30 Barry M. Tydings Assaying device and method for in field urinalysis
US6294349B1 (en) 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas
US7189397B2 (en) 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20040029114A1 (en) 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
ATE289685T1 (de) * 2003-08-25 2005-03-15 Mtm Lab Ag Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
JP4563186B2 (ja) 2004-02-16 2010-10-13 理研ビタミン株式会社 耐熱性が改善されたアントシアニン色素
WO2005095987A2 (en) * 2004-03-26 2005-10-13 University Of Miami Salivary soluble cd44: a molecular marker for head and neck cancer
WO2007129999A2 (en) 2004-07-14 2007-11-15 Biospectrum, Inc. Antiproliferative peptides and antibodies for their detection
US20090197285A1 (en) 2005-11-10 2009-08-06 University Of Kentucky Lung Cancer Diagnostic Assay
WO2007133725A1 (en) 2006-05-12 2007-11-22 University Of Miami Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
CN101230390A (zh) * 2007-12-07 2008-07-30 湖北大学 一种用于妇科恶性肿瘤早期筛选的基因芯片及其检测方法
EP2364371A4 (en) * 2008-11-24 2012-05-02 Univ Loma Linda BIOMARKER FOR DETECTING HEADS AND HALSTUMORS
AU2012340441A1 (en) 2011-11-15 2014-05-29 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

Also Published As

Publication number Publication date
BR112014011563A2 (pt) 2017-05-09
AU2020277155A1 (en) 2020-12-24
US20160305942A1 (en) 2016-10-20
IL232556A (en) 2017-12-31
EP2780714A1 (en) 2014-09-24
AU2018203361A1 (en) 2018-05-31
MX2014005887A (es) 2014-09-08
JP2014533372A (ja) 2014-12-11
EP2780714A4 (en) 2015-07-15
WO2013074793A1 (en) 2013-05-23
CN104067126A (zh) 2014-09-24
US20150219656A1 (en) 2015-08-06
PE20141565A1 (es) 2014-10-25
CA2855971C (en) 2022-01-04
CN104067126B (zh) 2017-04-12
US20140329230A1 (en) 2014-11-06
AU2012340441A1 (en) 2014-05-29
IL232556A0 (en) 2014-06-30
US10180431B2 (en) 2019-01-15
EP2780714B1 (en) 2017-08-16
US10180430B2 (en) 2019-01-15
BR112014011563B1 (pt) 2022-05-24
MX352642B (es) 2017-12-01
JP6174035B2 (ja) 2017-08-02
AU2018203361B2 (en) 2020-08-27
CA2855971A1 (en) 2013-05-23
CO6980621A2 (es) 2014-06-27

Similar Documents

Publication Publication Date Title
ES2640532T3 (es) Métodos para la detección de papilomavirus humano y proporcionar un pronóstico para el carcinoma de células escamosas de cabeza y cuello
JP5750152B2 (ja) 肝細胞癌と関連するシグネチャ遺伝子を利用する検査方法、及び該方法に用いられるアレイ又はキット
JP2006509185A (ja) 疾患状態の細胞ベースの検出および弁別
Xu et al. An in situ molecular signature to predict early recurrence in hepatitis B virus-related hepatocellular carcinoma
Ke et al. Expression characteristics of astrocyte elevated gene-1 (AEG-1) in tongue carcinoma and its correlation with poor prognosis
CN104407151B (zh) Kindlin-2，Myosin-9和Annexin II三蛋白联合预测食管鳞癌患者预后试剂盒
Ferris et al. Rapid molecular detection of metastatic head and neck squamous cell carcinoma as an intraoperative adjunct to sentinel lymph node biopsy
Luo et al. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer
Gilbert et al. Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors
Mehta et al. The mesenchymal state predicts poor disease-free survival in resectable non-small cell lung cancer
Sharma et al. Screening for gynaecological cancers
Dhuria et al. Clinicopathological and prognostic significance of Her-2/Neu immunoexpression in head and neck squamous cell carcinomas and its association with survival in Indian population
Snietura et al. Human papillomavirus DNA in pharyngeal scrapes as a marker of HPV-related squamous cell cancer of the oropharynx
KR102621347B1 (ko) p53 단백질 수준 또는 이를 암호화하는 유전자의 mRNA 발현 수준 측정 제제를 포함하는 위암 예측 또는 진단용 조성물
Zhang et al. Expression and clinical relations of protein tyrosine phosphatase receptor type S in esophageal squamous cell carcinoma
ES2381729B1 (es) Test predictor de supervivencia global de adenocarcinoma de pulmón
Franzmann Saliva as a diagnostic tool
Su et al. Current Insights into Oral Cancer Diagnostics. Diagnostics 2021, 11, 1287
Wang et al. Prognostic Significance of preoperative serum CA125, CA19-9, CA72-4, CEA, and AFP in Patients with Endometrial cancer
CN121555637A (zh) 预测辅助治疗对肿瘤疗效的标志物、试剂盒及用途
CN107779509A (zh) 一种肺癌诊断的标志物及其应用
CN120796474A (zh) Mpp2基因作为结肠癌预后标志物及治疗靶点的应用
CN104487595A (zh) 用于预测从巴雷特食管到高度发育异常食管腺癌的进展的方法
Lindell Etiologic, diagnostic and prognostic factors in vulvar cancer
Pecorelli Genomic and sieroproteomic analysis for the identification of molecular tumor markers for diagnosis, therapy and follow-up of ovarian and endometrial carcinomas